Tyra Bioscience's total assets for Q3 2024 were $380.59M, a decrease of -3.02% from the previous quarter. TYRA total liabilities were $18.30M for the fiscal quarter, a 11.49% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.